Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development.

Gao, Wei; Liu, Jiang; Shtylla, Blerta; Venkatakrishnan, Karthik; Yin, Donghua; Shah, Mirat; Nicholas, Timothy; Cao, Yanguang

Gao, Wei; Liu, Jiang; Shtylla, Blerta; Venkatakrishnan, Karthik; Yin, Donghua; Shah, Mirat; Nicholas, Timothy; Cao, Yanguang.

Afiliação

Gao W; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.
Liu J; Food and Drug Administration, Silver Spring, Maryland, USA.
Shtylla B; Quantitative Systems Pharmacology, Pfizer, San Diego, California, USA.
Venkatakrishnan K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.
Yin D; Clinical Pharmacology, Pfizer, San Diego, California, USA.
Shah M; Food and Drug Administration, Silver Spring, Maryland, USA.
Nicholas T; Pharmacometrics, Pfizer, Groton, Connecticut, USA.
Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

CPT Pharmacometrics Syst Pharmacol ; 2023 Nov 15.

Article em En | MEDLINE | ID: mdl-37969061

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google